BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33847457)

  • 1. Heterozygous variants in SPTBN1 cause intellectual disability and autism.
    Rosenfeld JA; Xiao R; Bekheirnia MR; Kanani F; Parker MJ; Koenig MK; van Haeringen A; Ruivenkamp C; Rosmaninho-Salgado J; Almeida PM; Sá J; Pinto Basto J; Palen E; Oetjens KF; Burrage LC; Xia F; Liu P; Eng CM; ; Yang Y; Posey JE; Lee BH
    Am J Med Genet A; 2021 Jul; 185(7):2037-2045. PubMed ID: 33847457
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Khan A; Bruno LP; Alomar F; Umair M; Pinto AM; Khan AA; Khan A; Saima ; Fabbiani A; Zguro K; Furini S; Mencarelli MA; Renieri A; Resciniti S; Peña-Guerra KA; Guzmán-Vega FJ; Arold ST; Ariani F; Khan SN
    Front Mol Neurosci; 2022; 15():877258. PubMed ID: 35782384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo heterozygous missense and loss-of-function variants in CDC42BPB are associated with a neurodevelopmental phenotype.
    Chilton I; Okur V; Vitiello G; Selicorni A; Mariani M; Goldenberg A; Husson T; Campion D; Lichtenbelt KD; van Gassen K; Steinraths M; Rice J; Roeder ER; Littlejohn RO; Srour M; Sebire G; Accogli A; Héron D; Heide S; Nava C; Depienne C; Larson A; Niyazov D; Azage M; Hoganson G; Burton J; Rush ET; Jenkins JL; Saunders CJ; Thiffault I; Alaimo JT; Fleischer J; Groepper D; Gripp KW; Chung WK
    Am J Med Genet A; 2020 May; 182(5):962-973. PubMed ID: 32031333
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Hubert L; Cannata Serio M; Villoing-Gaudé L; Boddaert N; Kaminska A; Rio M; Lyonnet S; Munnich A; Poirier K; Simons M; Besmond C
    J Med Genet; 2020 Feb; 57(2):138-144. PubMed ID: 31439720
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Roston A; Evans D; Gill H; McKinnon M; Isidor B; Cogné B; Mwenifumbo J; van Karnebeek C; An J; Jones SJM; Farrer M; Demos M; Connolly M; Gibson WT; ;
    J Med Genet; 2021 Mar; 58(3):196-204. PubMed ID: 32546566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delineating SPTAN1 associated phenotypes: from isolated epilepsy to encephalopathy with progressive brain atrophy.
    Syrbe S; Harms FL; Parrini E; Montomoli M; Mütze U; Helbig KL; Polster T; Albrecht B; Bernbeck U; van Binsbergen E; Biskup S; Burglen L; Denecke J; Heron B; Heyne HO; Hoffmann GF; Hornemann F; Matsushige T; Matsuura R; Kato M; Korenke GC; Kuechler A; Lämmer C; Merkenschlager A; Mignot C; Ruf S; Nakashima M; Saitsu H; Stamberger H; Pisano T; Tohyama J; Weckhuysen S; Werckx W; Wickert J; Mari F; Verbeek NE; Møller RS; Koeleman B; Matsumoto N; Dobyns WB; Battaglia D; Lemke JR; Kutsche K; Guerrini R
    Brain; 2017 Sep; 140(9):2322-2336. PubMed ID: 29050398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic SPTBN1 variants cause an autosomal dominant neurodevelopmental syndrome.
    Cousin MA; Creighton BA; Breau KA; Spillmann RC; Torti E; Dontu S; Tripathi S; Ajit D; Edwards RJ; Afriyie S; Bay JC; Harper KM; Beltran AA; Munoz LJ; Falcon Rodriguez L; Stankewich MC; Person RE; Si Y; Normand EA; Blevins A; May AS; Bier L; Aggarwal V; Mancini GMS; van Slegtenhorst MA; Cremer K; Becker J; Engels H; Aretz S; MacKenzie JJ; Brilstra E; van Gassen KLI; van Jaarsveld RH; Oegema R; Parsons GM; Mark P; Helbig I; McKeown SE; Stratton R; Cogne B; Isidor B; Cacheiro P; Smedley D; Firth HV; Bierhals T; Kloth K; Weiss D; Fairley C; Shieh JT; Kritzer A; Jayakar P; Kurtz-Nelson E; Bernier RA; Wang T; Eichler EE; van de Laar IMBH; McConkie-Rosell A; McDonald MT; Kemppainen J; Lanpher BC; Schultz-Rogers LE; Gunderson LB; Pichurin PN; Yoon G; Zech M; Jech R; Winkelmann J; ; ; Beltran AS; Zimmermann MT; Temple B; Moy SS; Klee EW; Tan QK; Lorenzo DN
    Nat Genet; 2021 Jul; 53(7):1006-1021. PubMed ID: 34211179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.
    Kim HG; Rosenfeld JA; Scott DA; Bénédicte G; Labonne JD; Brown J; McGuire M; Mahida S; Naidu S; Gutierrez J; Lesca G; des Portes V; Bruel AL; Sorlin A; Xia F; Capri Y; Muller E; McKnight D; Torti E; Rüschendorf F; Hummel O; Islam Z; Kolatkar PR; Layman LC; Ryu D; Kong IK; Madan-Khetarpal S; Kim CH
    Mol Autism; 2019; 10():35. PubMed ID: 31649809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic variants in
    Granadillo JL; P A Stegmann A; Guo H; Xia K; Angle B; Bontempo K; Ranells JD; Newkirk P; Costin C; Viront J; Stumpel CT; Sinnema M; Panis B; Pfundt R; Krapels IPC; Klaassens M; Nicolai J; Li J; Jiang Y; Marco E; Canton A; Latronico AC; Montenegro L; Leheup B; Bonnet C; M Amudhavalli S; Lawson CE; McWalter K; Telegrafi A; Pearson R; Kvarnung M; Wang X; Bi W; Rosenfeld JA; Shinawi M
    J Med Genet; 2020 Oct; 57(10):717-724. PubMed ID: 32152250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clustered mutations in the GRIK2 kainate receptor subunit gene underlie diverse neurodevelopmental disorders.
    Stolz JR; Foote KM; Veenstra-Knol HE; Pfundt R; Ten Broeke SW; de Leeuw N; Roht L; Pajusalu S; Part R; Rebane I; Õunap K; Stark Z; Kirk EP; Lawson JA; Lunke S; Christodoulou J; Louie RJ; Rogers RC; Davis JM; Innes AM; Wei XC; Keren B; Mignot C; Lebel RR; Sperber SM; Sakonju A; Dosa N; Barge-Schaapveld DQCM; Peeters-Scholte CMPCD; Ruivenkamp CAL; van Bon BW; Kennedy J; Low KJ; Ellard S; Pang L; Junewick JJ; Mark PR; Carvill GL; Swanson GT
    Am J Hum Genet; 2021 Sep; 108(9):1692-1709. PubMed ID: 34375587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic variants in USP7 cause a neurodevelopmental disorder with speech delays, altered behavior, and neurologic anomalies.
    Fountain MD; Oleson DS; Rech ME; Segebrecht L; Hunter JV; McCarthy JM; Lupo PJ; Holtgrewe M; Moran R; Rosenfeld JA; Isidor B; Le Caignec C; Saenz MS; Pedersen RC; Morgan TM; Pfotenhauer JP; Xia F; Bi W; Kang SL; Patel A; Krantz ID; Raible SE; Smith W; Cristian I; Torti E; Juusola J; Millan F; Wentzensen IM; Person RE; Küry S; Bézieau S; Uguen K; Férec C; Munnich A; van Haelst M; Lichtenbelt KD; van Gassen K; Hagelstrom T; Chawla A; Perry DL; Taft RJ; Jones M; Masser-Frye D; Dyment D; Venkateswaran S; Li C; Escobar LF; Horn D; Spillmann RC; Peña L; Wierzba J; Strom TM; Parenti I; Kaiser FJ; Ehmke N; Schaaf CP
    Genet Med; 2019 Aug; 21(8):1797-1807. PubMed ID: 30679821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel variants in SPTAN1 without epilepsy: An expansion of the phenotype.
    Gartner V; Markello TC; Macnamara E; De Biase A; Thurm A; Joseph L; Beggs A; Schmahmann JD; Berry GT; Anselm I; Boslet E; Tifft CJ; Gahl WA; Lee PR
    Am J Med Genet A; 2018 Dec; 176(12):2768-2776. PubMed ID: 30548380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De Novo and Dominantly Inherited SPTAN1 Mutations Cause Spastic Paraplegia and Cerebellar Ataxia.
    Van de Vondel L; De Winter J; Beijer D; Coarelli G; Wayand M; Palvadeau R; Pauly MG; Klein K; Rautenberg M; Guillot-Noël L; Deconinck T; Vural A; Ertan S; Dogu O; Uysal H; Brankovic V; Herzog R; Brice A; Durr A; Klebe S; Stock F; Bischoff AT; Rattay TW; Sobrido MJ; De Michele G; De Jonghe P; Klopstock T; Lohmann K; Zanni G; Santorelli FM; Timmerman V; Haack TB; Züchner S; ; Schüle R; Stevanin G; Synofzik M; Basak AN; Baets J
    Mov Disord; 2022 Jun; 37(6):1175-1186. PubMed ID: 35150594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo mutations in HNRNPU result in a neurodevelopmental syndrome.
    Yates TM; Vasudevan PC; Chandler KE; Donnelly DE; Stark Z; Sadedin S; Willoughby J; ; ; Balasubramanian M
    Am J Med Genet A; 2017 Nov; 173(11):3003-3012. PubMed ID: 28944577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deleterious Variation in BRSK2 Associates with a Neurodevelopmental Disorder.
    Hiatt SM; Thompson ML; Prokop JW; Lawlor JMJ; Gray DE; Bebin EM; Rinne T; Kempers M; Pfundt R; van Bon BW; Mignot C; Nava C; Depienne C; Kalsner L; Rauch A; Joset P; Bachmann-Gagescu R; Wentzensen IM; McWalter K; Cooper GM
    Am J Hum Genet; 2019 Apr; 104(4):701-708. PubMed ID: 30879638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo truncating variants in the intronless IRF2BPL are responsible for developmental epileptic encephalopathy.
    Tran Mau-Them F; Guibaud L; Duplomb L; Keren B; Lindstrom K; Marey I; Mochel F; van den Boogaard MJ; Oegema R; Nava C; Masurel A; Jouan T; Jansen FE; Au M; Chen AH; Cho M; Duffourd Y; Lozier E; Konovalov F; Sharkov A; Korostelev S; Urteaga B; Dickson P; Vera M; Martínez-Agosto JA; Begemann A; Zweier M; Schmitt-Mechelke T; Rauch A; Philippe C; van Gassen K; Nelson S; Graham JM; Friedman J; Faivre L; Lin HJ; Thauvin-Robinet C; Vitobello A
    Genet Med; 2019 Apr; 21(4):1008-1014. PubMed ID: 30166628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel in-frame de novo mutation in SPTAN1 in intellectual disability and pontocerebellar atrophy.
    Hamdan FF; Saitsu H; Nishiyama K; Gauthier J; Dobrzeniecka S; Spiegelman D; Lacaille JC; Décarie JC; Matsumoto N; Rouleau GA; Michaud JL
    Eur J Hum Genet; 2012 Jul; 20(7):796-800. PubMed ID: 22258530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo variants in PAK1 lead to intellectual disability with macrocephaly and seizures.
    Horn S; Au M; Basel-Salmon L; Bayrak-Toydemir P; Chapin A; Cohen L; Elting MW; Graham JM; Gonzaga-Jauregui C; Konen O; Holzer M; Lemke J; Miller CE; Rey LK; Wolf NI; Weiss MM; Waisfisz Q; Mirzaa GM; Wieczorek D; Sticht H; Abou Jamra R
    Brain; 2019 Nov; 142(11):3351-3359. PubMed ID: 31504246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic expansion of POGZ-related intellectual disability syndrome (White-Sutton syndrome).
    Assia Batzir N; Posey JE; Song X; Akdemir ZC; Rosenfeld JA; Brown CW; Chen E; Holtrop SG; Mizerik E; Nieto Moreno M; Payne K; Raas-Rothschild A; Scott R; Vernon HJ; Zadeh N; ; Lupski JR; Sutton VR
    Am J Med Genet A; 2020 Jan; 182(1):38-52. PubMed ID: 31782611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterozygous ANKRD17 loss-of-function variants cause a syndrome with intellectual disability, speech delay, and dysmorphism.
    Chopra M; McEntagart M; Clayton-Smith J; Platzer K; Shukla A; Girisha KM; Kaur A; Kaur P; Pfundt R; Veenstra-Knol H; Mancini GMS; Cappuccio G; Brunetti-Pierri N; Kortüm F; Hempel M; Denecke J; Lehman A; ; Kleefstra T; Stuurman KE; Wilke M; Thompson ML; Bebin EM; Bijlsma EK; Hoffer MJV; Peeters-Scholte C; Slavotinek A; Weiss WA; Yip T; Hodoglugil U; Whittle A; diMonda J; Neira J; Yang S; Kirby A; Pinz H; Lechner R; Sleutels F; Helbig I; McKeown S; Helbig K; Willaert R; Juusola J; Semotok J; Hadonou M; Short J; ; Yachelevich N; Lala S; Fernández-Jaen A; Pelayo JP; Klöckner C; Kamphausen SB; Abou Jamra R; Arelin M; Innes AM; Niskakoski A; Amin S; Williams M; Evans J; Smithson S; Smedley D; de Burca A; Kini U; Delatycki MB; Gallacher L; Yeung A; Pais L; Field M; Martin E; Charles P; Courtin T; Keren B; Iascone M; Cereda A; Poke G; Abadie V; Chalouhi C; Parthasarathy P; Halliday BJ; Robertson SP; Lyonnet S; Amiel J; Gordon CT
    Am J Hum Genet; 2021 Jun; 108(6):1138-1150. PubMed ID: 33909992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.